Investors are rushing into California to get a piece of the state's cannabis business as legalization is set to go on the ballot.
During a third-quarter earnings call, Monsanto management said talks with German suitor Bayer and other parties are ongoing.
West Virginia floods could cost agribusinesses more than $10 million in losses, though the exact amount is still being tallied.
The pace of mergers and acquisitions in agribusiness shows no signs of letting up.
Weird weather this year, in part resulting from El Nino, has "completely decimated" northeastern stone fruit crops.
Mosaic, the world's top producer of concentrated phosphate, has entered talks to buy Vale's fertilizer unit, sources familiar with the matter said.
PhosAgro CEO, Andrey Guryev explains why Russia's agricultural sector has fantastic potential.
A high demand and short supply of the green superfood have triggered an avocado-related crime wave in New Zealand.
A combination of buoyant demand and supply-side jitters is supporting prices of soybeans and corn after several years of glut-driven pessimism.
Bunge CEO Soren Schroder says agricultural commodities might be unpredictable but irrespective of price levels, demand continues to grow.
Janus Capital Group SVP Nick Cherney weighs in on Janus Capital launching four new health & wellness ETFs.
The drought wreaking havoc in Southeast Asia looks set to fall off the agenda at a key meeting of the region's political and financial leaders this week.
California's economy is on fire but the state's finances are another story and the governor is warning of a slowdown or recession down the road.
Stephen Macklow-Smith, head of Europe equities strategy at JPMorgan, and Steen Jakobsen, Saxo Bank chief economist, discuss Tate & Lyle and sugar.
Dennis Gartman, founder, editor & publisher of The Gartman Letter, comments on Monsanto's decision to reject the Bayer acquisition proposal.
Kirsty Wilson, senior analyst at Mergermarket, looks at the potential bidders for U.S. agrichemicals giant Monsanto, including potential interest from China.
Neil Dwane, global strategist at Allianz Global Investors, says many Bayer investors will view the deal negatively as they won't own Monsanto.
John Rountree, managing partner at Novasecta, talks about whether or not the Bayer-Monsanto merger would create more or less innovation and value.
Just when you thought the dearth of M&A in Europe was here to stay, Bayer sweeps in with a $62 billion bid for U.S. giant Monsanto.
Werner Baumann, Bayer CEO, weighs in on the tax ramification of the combined companies.